Back to search

Article

Targeting RNF8 Effectively Reverse Cisplatin and Doxorubicin Resistance in Endometrial Cancer

2020-09-02

Abstract excerpt

<title>Abstract</title> <p>Background Endometrial cancer (EC) is one of the most frequent gynecological malignancy worldwide. However, resistance to chemotherapy remains one of the major difficulties in the treatment of EC. Thus, there is an urgent requirement to understand mechanisms of chemoresistance and identify novel regimens for patients with EC. Methods Cisplatin and doxorubicin resistant cell lines were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
782ffc58-1675-57c6-91ce-3ed69abe5d11
DOI
10.21203/rs.3.rs-57263/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting RNF8 Effectively Reverse Cisplatin and Doxorubicin Resistance in Endometrial CancerDOI 10.21203/rs.3.rs-57263/v1
Select a neighboring publication to make it the new centre.